Get Level 2

SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Rtw Biotech Share Price
  4. Rtw Biotech Share Regulatory News
  5. Spectris

Pin to quick picksRtw Biotech Regulatory News (RTW)

Rtw Biotech Information

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Spectris

1 Dec 2025 18:00

RNS Number : 7232J
FTSE Russell
01 December 2025
 

 

 

Further to the FTSE Russell notice released on 25 November 2025 in relation to Spectris (UK): Constituent Deletion, please note the FTSE 250 Index replacement and associated changes.

 

All other details remain unchanged. Please see updated notice below:

Spectris (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

01 December 2025

Subject to court sanctioning the scheme of arrangement for the cash offer for Spectris (UK, constituent) by Aurora Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

 

Spectris (UK, 0330860) will be deleted from the FTSE 250 Index.

 

RTW Biotech Opportunities (UK, BKTRRM2) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes effective from the open of Thursday 04 December 2025.

 

Full details of changes are available on the FTSE Russell website.

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSTBBJTMTMMBIA
12345678910
Date   Source Headline
12th Jun 20267:00 amRNSMonthly Valuation Update and Factsheet
11th Jun 20264:45 pmRNSResult of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 20267:00 amRNSNotice of AGM
14th May 20267:00 amRNSMonthly Valuation Update and Factsheet
12th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSAdditional investment in Windward Bio
6th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20263:00 pmRNSAnnual Financial Report
24th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSKailera completes $625 million IPO
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSReplacement RNS: Monthly Valuation Update
15th Apr 20267:01 amRNSObsidian Therapeutics reverse merger with Galera
15th Apr 20267:00 amRNSMonthly Valuation Update and Factsheet
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:01 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSApellis and Centessa to be acquired
31st Mar 20267:01 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSAmani closes $25 million Series A financing
30th Mar 20267:01 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Financial Report
27th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
LC83
Barclays 29
LSE
0.00%
JC91
Citi Fun 26
LSE
0.00%
FGP
Firstgroup
LSE
0.82%
0GV5
Gvs Spa
LSE
0.00%
UB0A
Ubs Etf Ub0a
LSE
2.30%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-43.75%
MPAL
Medpal AI
LSE
33.87%
NANO
Nanoco
LSE
18.64%
IMM
Immupharma
LSE
5.42%
ITM
Itm Power
LSE
8.98%